American Century Companies’s Flexion Therapeutics, Inc. FLXN Stock Holding History

American Century Companies’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-703,044	Closed	-$5.79M	–	2374
2021 Q2	$5.79M	Buy	703,044 +1,255	+0.2%	+$10.7K	﹤0.01%	955
2021 Q1	$6.28M	Buy	701,789 +52,081	+8%	+$597K	﹤0.01%	876
2020 Q4	$7.5M	Buy	649,708 +53,509	+9%	+$622K	0.01%	812
2020 Q3	$6.21M	Sell	596,199 -51,671	-8%	-$633K	0.01%	781
2020 Q2	$8.52M	Buy	647,870 +350,744	+118%	+$3.64M	0.01%	715
2020 Q1	$2.34M	Sell	297,126 -38,938	-12%	-$586K	﹤0.01%	826
2019 Q4	$6.96M	Buy	336,064 +112,380	+50%	+$1.9M	0.01%	756
2019 Q3	$3.07M	Buy	223,684 +55,212	+33%	+$655K	﹤0.01%	895
2019 Q2	$2.07M	Sell	168,472 -356	-0.2%	-$4.11K	﹤0.01%	1017
2019 Q1	$2.11M	Sell	168,828 -6,952	-4%	-$92.9K	﹤0.01%	984
2018 Q4	$1.99M	Buy	175,780 +3,666	+2%	+$57.5K	﹤0.01%	975
2018 Q3	$3.22M	Buy	172,114 +41,752	+32%	+$959K	﹤0.01%	942
2018 Q2	$3.37M	Buy	130,362 +336	+0.3%	+$8.72K	﹤0.01%	927
2018 Q1	$2.91M	Buy	130,026 +14,517	+13%	+$354K	﹤0.01%	941
2017 Q4	$2.89M	Buy	115,509 +7,483	+7%	+$183K	﹤0.01%	949
2017 Q3	$2.61M	Buy	108,026 +724	+0.7%	+$17K	﹤0.01%	994
2017 Q2	$2.17M	Sell	107,302 -990	-0.9%	-$20.6K	﹤0.01%	1022
2017 Q1	$2.91M	Sell	108,292 -1,469	-1%	-$30K	﹤0.01%	986
2016 Q4	$2.09M	Buy	109,761 +27,499	+33%	+$526K	﹤0.01%	1031
2016 Q3	$1.61M	Buy	+82,262	New	+$1.39M	﹤0.01%	1091

Other funds holding FLXN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies's FLXN Position: Q3 2021 in Review

American Century Companies sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2021, closing a stake of 703,044 shares — an estimated $5.79M sold.

American Century Companies first reported a position in FLXN in Q3 2016 and held it in 20 quarters. The position peaked at $8.52M in Q2 2020. 145 funds tracked by Wall St. Rank hold FLXN as of Q3 2021.

American Century Companies reported no remaining Flexion Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
American Century Companies sold 703,044 Flexion Therapeutics, Inc. shares in Q3 2021, an estimated $5.79M.
American Century Companies first reported a position in Flexion Therapeutics, Inc. in Q3 2016 and held it in 20 quarters.
American Century Companies's Flexion Therapeutics, Inc. position peaked at $8.52M in Q2 2020.
145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2021.

Based on American Century Companies's 13F filing for Q3 2021, filed 10 Nov 2021.